MBOAT2 and mesothelioma: High MBOAT2 expression correlates with a worse prognosis in several cancers, including PC, adrenocortical carcinoma, mesothelioma, uveal melanoma, and urothelial carcinoma, yet it is associated with longer survival in kidney renal clear cell carcinoma.